ARTICLE
16 April 2026

Life Sciences And Healthcare M&A 2025: A Year In Review

AC
Arthur Cox

Contributor

Arthur Cox is one of Ireland’s leading law firms. For almost 100 years, we have been at the forefront of developments in the legal profession in Ireland. Our practice encompasses all aspects of corporate and business law. The firm has offices in Dublin, Belfast, London, New York and Silicon Valley.
This report examines how deal activity in the life sciences and healthcare sector performed during 2025, highlighting key trends, significant transactions and emerging themes shaping the market. The report also looks ahead to 2026, considering the factors likely to influence M&A activity in Ireland in the year ahead.
Ireland Food, Drugs, Healthcare, Life Sciences
Colin Kavanagh’s articles from Arthur Cox are most popular:
  • within Food, Drugs, Healthcare and Life Sciences topic(s)
Arthur Cox are most popular:
  • within Law Department Performance and Antitrust/Competition Law topic(s)

This report examines how deal activity in the life sciences and healthcare sector performed during 2025, highlighting key trends, significant transactions and emerging themes shaping the market. The report also looks ahead to 2026, considering the factors likely to influence M&A activity in Ireland in the year ahead.

Click below to read the full report:

1774086a.jpg

This article contains a general summary of developments and is not a complete or definitive statement of the law. Specific legal advice should be obtained where appropriate.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More